We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current DRUG market cap is 1.32B. The company's latest EPS is AUD 0.0442 and P/E is 189.14.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 2.9M | 3.92M | 15.62M | 2.46M | 7.94M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 2.7M | 3.66M | 15.13M | 1.57M | 6.99M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 31.08M | 49.56M | 115.11M | 165.11M | 161.45M |
| Total Liabilities | 15k | 1.52M | 7.35M | 6.3M | 3.22M |
| Total Equity | 31.07M | 48.04M | 107.76M | 158.81M | 158.23M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -3.79M | -12.34M | -50.55M | -44.16M | 7.28M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 3.77M | 12.34M | 50.67M | 44.38M | -7.57M |
| Market Cap | 1.32B |
| Price to Earnings Ratio | 189.14 |
| Price to Sales Ratio | 166.53 |
| Price to Cash Ratio | 11.94k |
| Price to Book Ratio | 8.36 |
| Dividend Yield | - |
| Shares Outstanding | 158.23M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (0.48%) |
| Company Name | BetaShares Capital Limited |
| Address |
level 11 sydney, new south wales 2000 |
| Website | https://www.betashares.com.au |
| Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
